Book Review: Dear Shareholder
4 mins. to read
Richard Gill, CFA, reviews Dear Shareholder: The Best Executive Letters from Warren Buffet, Prem Watsa and other great CEOs.
Latest
Three charts to watch in the month ahead
6 mins. to read
Michael Taylor uncovers some of the trading opportunities being thrown up by the ongoing market volatility.
Royal Bank of Scotland rises after quarterly update
0 mins. to read
Royal Bank of Scotland saw its share price climb by 4.75% despite total income dropping by 1.6% during the first quarter.
Year-end update lifts James Cropper
0 mins. to read
The price of shares in AIM-listed James Cropper rose by 3.83% after the company reported that adjusted pre-tax profits for the year ended 28th March would be well ahead of expectations.
Kromek’s end-of-year statement triggers sell-off
0 mins. to read
The price of shares in detection specialist Kromek Group tumbled 12.92% after it said that business had been impacted since the end of February.
Stocks in Focus: DXS International
6 mins. to read
An accredited NHS software creator is poised to enter a new growth phase with next-generation, digital, clinical-support engines, as healthcare systems worldwide feel the strain.
Small-cap round-up: featuring Robinson, MP Evans, Loungers and more…
3 mins. to read
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Evil Knievil: Oil over the place
1 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
A Journal of the Plague Year – Part the First
12 mins. to read
Daniel Defoe (of Robinson Crusoe fame) published his Journal of the Plague Year in 1722 – an eye-witness account of the Great Plague in London of 1665. How plagues play out can teach us lessons today. Victor Hill has begun to keep such a journal.
Hikma Pharmaceuticals up ahead of AGM
1 mins. to read
The price of shares in drug manufacturer Hikma Pharmaceuticals rose 4.72% after the firm announced that it had a successful start to the year across its divisions.